02Dec
UK Life Sciences and Healthcare Newsletter - December 2020: The UK National Security and Investment Bill
The UK has announced a bill proposing a new system to screen transactions for national security risk, separate from the system of merger review operated by the Competition and Markets Authority. The National Security and Investment Bill has been in the pipeline since the publication of the National Security Risk Assessment in 2015, but has been delayed due to Brexit and the COVID-19 pandemic....
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-53811/
Related
NuVasive Inc. v. Miles, C.A. No. 2017-0720-SG (Del. Ch. Aug. 26, 2019). When a contract, executed b...
Read More >
Several industry updates that affect manufactured housing either take effect October 1, 2020, or wil...
Read More >
If you are involved in the construction industry, you have probably heard of or dealt with mechanic’...
Read More >
Baseline HSR threshold now $92 million The Hart-Scott-Rodino Act requires that parties to certain tr...
Read More >
A recent Advice Memorandum from the National Labor Relations Board’s (NLRB) General Counsel’s offi...
Read More >
A non-compete agreement, which is often referred to as a “restrictive covenant,” attempts to precl...
Read More >